Listed
Stock Code: 188260
| Company Name | (주)세니젠 |
| English Name | SANIGEN Co., Ltd. |
| Business Reg. No. | 2208716524 |
| CEO | 박정웅 |
| Address | 경기도 안양시 동안구 흥안대로427번길 16, 411호 |
| Industry | 그 외 기타 의료용 기기 제조업 |
| Industry Code | 339 |
| Established | 20050928 |
| Phone | 18338010 |
| Website | sanigen.kr |
| Regular Employees | 88persons |
| Corp. Reg. No. | 1101113313254 |
Venture Certified
| 기술평가보증기업(기금) | 2012-04-27 ~ 2014-04-26 | 20120103884 | 2012-04-27 |
| 벤처투자유형 | 2018-03-08 ~ 2020-03-07 | 20180300159 | 2012-04-27 |
| 벤처투자유형 | 2020-03-08 ~ 2022-03-07 | 20200300177 | 2012-04-27 |
| 벤처투자유형 | 2022-03-08 ~ 2025-03-07 | 20220316010065 | 2012-04-27 |
| 벤처투자유형 | 2025-03-08 ~ 2028-03-07 | 20250402010001 | 2012-04-27 |
Revenue CAGR -24.1%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 154B | 202B | 268B |
| Operating Profit | -59B | -65B | -41B |
| Net Profit | -66B | -92B | -41B |
| Total Assets | 147B | 210B | 156B |
| Total Liabilities | 64B | 76B | 286B |
| Total Equity | 82B | 134B | -129B |
Operating Loss: Op. profit -59B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+22pp YoY)
▼ 34.3%
▼ 11.3%
▼ 60.9%
▲ 195.2%
▼ 323.6%
| Name | Position | Role | Comp. (M KRW) |
|---|---|---|---|
| 박정웅 | 사내이사 | 경영총괄 | - |
| 김영재 | 사내이사 | 부사장/ 영업본부장 | - |
| 최진호 | 사내이사 | R&D센터장 | - |
| 심성진 | 미등기 | 경영지원 본부장 | - |
| 전경일 | 미등기 | 영업이사 | - |
| 송시범 | 미등기 | 생산본부장 | - |
| 유상열 | 사외이사 | 사외이사 | - |
| 최영붕 | 감사 | 감사 | - |
| Shareholder | Ownership (%) | Shares Held |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - | ||
| - |
| NPS Subscribers | 64persons |
| CEO | 박정웅 |
| Est. Avg. Annual Salary | 4,48710K (37410K/mo) |
| Hired (12 mo) | +0persons |
| Left (12 mo) | -2persons |
| Net Change (12 mo) | -2persons |
| NPS Join Date | 2005-12-01 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "경기도 안양시 동안구 흥안대로427번길",
"brno": "220871****",
"cappedWarning": false,
"companyName": "(주)세니젠",
"estimatedAvgAnnualSalary": 44871948,
"estimatedAvgMonthlySalary": 3739329,
"fetchedAt": "2026-03-05T20:14:50.871Z",
"industryCode": "513311",
"industryName": "의약품 도매업",
"joinDate": "20051201",
"last12MonthsHired": 0,
"last12MonthsLeft": 2,
"last12MonthsNetChange": -2,
"leaveDate": null,
"monthlyPensionAmount": 22735120,
"monthlyTrend": [
{
"lostSubscribers": 2,
"newSubscribers": 0,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6362352",
"status": "1",
"styleCode": "1",
"subscriberCount": 64,
"turnoverMonths": 1
}{
"address": "경기도 안양시",
"ceo_name": "박정웅",
"certificate": [
{
"cert_number": "20120103884",
"changes": "",
"disclosure_date": "2012-04-27",
"first_cert_date": "2012-04-27",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-04-27 ~ 2014-04-26"
},
{
"cert_number": "20180300159",
"changes": "",
"disclosure_date": "2018-03-08",
"first_cert_date": "2012-04-27",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2018-03-08 ~ 2020-03-07"
},
{
"cert_number": "20200300177",
"changes": "",
"disclosure_date": "2020-02-27",
"first_cert_date": "2012-04-27",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2020-03-08 ~ 2022-03-07"
},
{
"cert_number": "20220316010065",
"changes": "",
"disclosure_date": "2022-03-16",
"first_cert_date": "2012-04-27",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2022-03-08 ~ 2025-03-07"
},
{
"cert_number": "20250402010001",
"changes": "",
"disclosure_date": "2025-04-02",
"first_cert_date": "2012-04-27",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2025-03-08 ~ 2028-03-07"
}
],
"company_name": "주식회사 세니젠",
"financials": {
"2022": {
"capital_stock": 1342450000,
"cost_of_sales": 22862051000,
"current_assets": 10007425000,
"current_liabilities": 25191494000,
"gross_profit": 3895713000,
"net_income": -4064853000,
"net_income_bs": -4064853000,
"non_current_assets": 5627564000,
"non_current_liabilities": 3367208000,
"non_operating_expenses": 1445487000,
"non_operating_income": 1463045000,
"operating_profit": -4082411000,
"revenue": 26757764000,
"sga_expenses": 7978124000,
"total_assets": 15634989000,
"total_equity": -12923714000,
"total_liabilities": 28558703000
},
"2023": {
"capital_stock": 3376169000,
"cost_of_sales": 19229612000,
"current_assets": 16780088000,
"current_liabilities": 2647528000,
"gross_profit": 3038868000,
"net_income": -8833156000,
"net_income_bs": -8775101000,
"non_current_assets": 4668359000,
"non_current_liabilities": 4933731000,
"non_operating_expenses": 2839877000,
"non_operating_income": 322400000,
"operating_profit": -6315679000,
"revenue": 22268480000,
"sga_expenses": 9354547000,
"total_assets": 21448447000,
"total_equity": 13867188000,
"total_liabilities": 7581258000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [
{
"amount": "2,000,000,000",
"changes": "2,000,000,000",
"date": "2021-06-30"
},
{
"amount": "1,600,005,000",
"changes": "1,600,005,000",
"date": "2021-06-10"
},
{
"amount": "1,999,998,000",
"changes": "1,999,998,000",
"date": "2017-12-27"
},
{
"amount": "1,999,000,000",
"changes": "1,999,000,000",
"date": "2017-12-27"
},
{
"amount": "499,000,000",
"changes": "499,000,000",
"date": "2017-12-16"
}
],
"phone": "1833****",
"source": "pg_migration"
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | DART | Collected |
| Investment Metrics | DART | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| nps | 2026-03-05 | Collected |
| Venture System Detail | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |